Common Contracts
2 similar License Agreement contracts by Inovio Pharmaceuticals, Inc.
LICENSE AGREEMENTLicense Agreement • April 16th, 2020 • Delaware
WHEREAS, Inovio has developed novel SynCon® DNA vaccine construct technology that may enable development of synthetic DNA vaccines targeted against, among other things, HPV-driven cancers (including the DNA vaccine known as INO-3112); and
DNA CANCER VACCINE COLLABORATION AND LICENSE AGREEMENTLicense Agreement • November 9th, 2015 • Inovio Pharmaceuticals, Inc. • Surgical & medical instruments & apparatus • Delaware
